Wealth Intelligence: The Molecule and the Map
Merck handed Aspen the right to make a once-monthly HIV pill across 129 countries. It is the second pharma prize Africa's largest drugmaker has landed this month.
Skip to content
Merck handed Aspen the right to make a once-monthly HIV pill across 129 countries. It is the second pharma prize Africa's largest drugmaker has landed this month.
Stephen Saad said you have to be within six months of the first launch to be part of market formation. This week Africa's largest drugmaker won approval to sell a generic Ozempic in Canada — and then discovered it has no ingredient to make it with.
Johann Rupert spent months examining a "potentially very significant" investment — and walked away. Reinet is now buying back up to €500 million of its own shares instead, sitting on the largest cash pile in its history.
In 1989 a Cameroonian banker submitted a doctoral thesis in Bordeaux arguing that Africa's informal economy was not a failure but a financial revolution waiting for its institution. He then spent 36 years building the institution. Last week it opened in one of the least-banked countries on earth.
A record $363 million dividend, a 95% jump in profit, and a bet to become Nigeria's largest food manufacturer by next year. Inside Abdul Samad Rabiu's plan to win the staple-food market on sheer volume.
Aliko Dangote has raised about $2.5 billion privately at a ~$40 billion valuation, days before floating the refinery on the Nigerian Exchange. Last week we called the IPO the hinge of his whole network. This is the hinge turning.
A hotel room in South Africa, three months long, where a banker watched his wife die of cancer. Out of it came Malawi's only cancer hospital — and the most revealing chapter in the complicated story of the country's first billionaire, Thom Mpinganjira.
A European heatwave, an AfCFTA loophole and a $1 billion family conglomerate: how Abderrahmane Benhamadi's Condor is trying to turn Algeria into an exporter of something other than oil and gas.
Femi Otedola is a Forbes-listed billionaire and the author of one of the boldest bets in Nigerian banking. Yesterday his First HoldCo stake hit a record $530 million. Inside the holdings, the cash flows and the pivot behind the number.
Nassef Sawiris has crossed 55% of OCI Global and won his board's backing for a €4.10 all-cash offer. Inside the take-private — and the Orascom question riding alongside it.
He is worth close to $9 billion, yet absent from the Forbes list. His flagship Moroccan refinery lies in ruins. And he is quietly pouring capital back into Ethiopia. The paradox of Mohammed Al-Amoudi.
How Aliko Dangote's $17 billion Lamu bet turns a single plant into a continental system — and what it signals about the IPO to come.
This week, Angola begins selling shares in Unitel the telecom giant it took from Isabel dos Santos, once Africa’s richest woman. The IPO of a seized fortune, and the unresolved fight over how it was built and how it was taken.
He ran Gabon’s oil for 13 years, built a near-billion-dollar private energy empire from Geneva and has spent a decade trying to build Benin a trade corridor to the Sahel. This week, the first trains of that dream finally moved.
He built Capitec for the customers South Africa’s banks ignored — and rode it to a $3.8 billion fortune as the lender became Africa’s most valuable bank.
Africa’s second-richest man controls Cartier, a healthcare empire and a web of listed holdings — quietly, from Stellenbosch. As Remgro seizes full control of Mediclinic, a full read of the Rupert fortune.